# Biomarin Pharmaceutical Inc: filings

BMRN · Nasdaq · CIK 1048477 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bmrn.md) · [Financials](/companies/bmrn/financials.md) · [Filings](/companies/bmrn/filings.md) · [Insiders](/companies/bmrn/insiders.md)

## Reports and events: 320 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1290, 8-K 213, SC 13G/A 95, 10-Q 53, 144 52, 5 50, 4/A 33, 3 29, SC 13G 20, DEFA14A 19, UPLOAD 19, 10-K 18, DEF 14A 18, CT ORDER 15, CORRESP 13, 424B5 12, S-8 12, ARS 11, SC TO-C 11, SC TO-T/A 10, 8-K/A 8, SCHEDULE 13G/A 8, S-8 POS 7, SC 13D/A 4, FWP 3, S-3ASR 3, SC 13D 3, 10-Q/A 2, SC TO-T 2, 10-K/A 1, 305B2 1, 3/A 1, 8-A12G/A 1, EFFECT 1, NO ACT 1, POS AM 1, PRE 14A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 20:22 ET | [8-K](/filings/0001048477-26-000019.md) | 2.02 Results of operations | 0001048477-26-000019 |
| 2026-09-30 | 20:15 ET | [8-K](/filings/0001628280-26-063981.md) | 1.01 Entry into a material agreement | 0001628280-26-063981 |
| 2026-09-15 | 12:31 ET | [8-K](/filings/0001628280-26-061973.md) | 8.01 Other events | 0001628280-26-061973 |
| 2026-09-14 | 13:26 ET | [8-K](/filings/0001628280-26-061717.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-061717 |
| 2026-09-01 | 13:23 ET | [8-K](/filings/0001193125-26-377696.md) | 8.01 Other events | 0001193125-26-377696 |
| 2026-08-31 | 10:01 ET | [8-K](/filings/0001193125-26-375275.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-375275 |
| 2026-08-18 | 12:39 ET | [8-K](/filings/0001193125-26-354780.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-354780 |
| 2026-08-06 | 20:14 ET | [10-Q](/filings/0001048477-26-000016.md) | Quarterly report, period 2026-06-30 | 0001048477-26-000016 |
| 2026-08-06 | 20:06 ET | [8-K](/filings/0001048477-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000015 |
| 2026-07-13 | 20:06 ET | [8-K/A](/filings/0001048477-26-000011.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001048477-26-000011 |
| 2026-06-04 | 20:24 ET | [8-K](/filings/0001628280-26-040812.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-26-040812 |
| 2026-05-05 | 17:59 ET | [10-Q](/filings/0001048477-26-000008.md) | Quarterly report, period 2026-03-31 | 0001048477-26-000008 |
| 2026-05-04 | 20:07 ET | [8-K](/filings/0001048477-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000006 |
| 2026-04-27 | 12:45 ET | [8-K](/filings/0001193125-26-179243.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-179243 |
| 2026-04-23 | 20:20 ET | [8-K](/filings/0001193125-26-173770.md) | 8.01 Other events | 0001193125-26-173770 |
| 2026-04-21 | 20:19 ET | [DEF 14A](/filings/0001628280-26-026290.md) | Proxy statement, period 2026-06-02 | 0001628280-26-026290 |
| 2026-03-16 | 12:30 ET | [8-K](/filings/0001193125-26-107314.md) | 8.01 Other events | 0001193125-26-107314 |
| 2026-02-26 | 17:30 ET | [10-K](/filings/0001048477-26-000004.md) | Annual report, period 2025-12-31 | 0001048477-26-000004 |
| 2026-02-23 | 21:08 ET | [8-K](/filings/0001048477-26-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000002 |
| 2026-02-12 | 21:11 ET | [8-K](/filings/0001193125-26-048736.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-048736 |
| 2026-01-29 | 21:19 ET | [8-K](/filings/0001193125-26-029401.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-029401 |
| 2026-01-26 | 12:54 ET | [8-K](/filings/0001193125-26-021718.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-021718 |
| 2026-01-12 | 21:44 ET | [8-K](/filings/0001193125-26-010508.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-010508 |
| 2025-12-22 | 14:00 ET | [8-K](/filings/0001193125-25-327828.md) | 8.01 Other events | 0001193125-25-327828 |
| 2025-12-19 | 13:47 ET | [8-K](/filings/0001193125-25-325856.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-325856 |
| 2025-12-17 | 21:06 ET | [8-K](/filings/0001193125-25-322704.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-322704 |
| 2025-10-28 | 18:07 ET | [10-Q](/filings/0001048477-25-000107.md) | Quarterly report, period 2025-09-30 | 0001048477-25-000107 |
| 2025-10-27 | 20:08 ET | [8-K](/filings/0001048477-25-000104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000104 |
| 2025-10-07 | 21:17 ET | [8-K](/filings/0001048477-25-000101.md) | 2.02 Results of operations | 0001048477-25-000101 |
| 2025-08-11 | 20:02 ET | [8-K](/filings/0001048477-25-000098.md) | 5.02 Departure or appointment of officers or directors | 0001048477-25-000098 |
| 2025-08-05 | 17:03 ET | [10-Q](/filings/0001048477-25-000090.md) | Quarterly report, period 2025-06-30 | 0001048477-25-000090 |
| 2025-08-04 | 20:04 ET | [8-K](/filings/0001048477-25-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000088 |
| 2025-08-01 | 20:28 ET | [8-K](/filings/0001048477-25-000086.md) | 5.02 Departure or appointment of officers or directors | 0001048477-25-000086 |
| 2025-05-22 | 20:05 ET | [8-K](/filings/0001193125-25-125040.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-125040 |
| 2025-05-16 | 11:54 ET | [8-K](/filings/0001193125-25-121296.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-121296 |
| 2025-05-02 | 16:33 ET | [10-Q](/filings/0001048477-25-000051.md) | Quarterly report, period 2025-03-31 | 0001048477-25-000051 |
| 2025-05-01 | 20:08 ET | [8-K](/filings/0001048477-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000049 |
| 2025-04-08 | 20:09 ET | [DEF 14A](/filings/0001048477-25-000045.md) | Proxy statement, period 2025-05-20 | 0001048477-25-000045 |
| 2025-03-03 | 21:05 ET | [8-K](/filings/0001193125-25-044103.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-044103 |
| 2025-02-24 | 21:30 ET | [8-K](/filings/0001193125-25-033463.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-033463 |
| 2025-02-24 | 18:54 ET | [10-K](/filings/0001048477-25-000007.md) | Annual report, period 2024-12-31 | 0001048477-25-000007 |
| 2025-02-19 | 21:07 ET | [8-K](/filings/0001048477-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000004 |
| 2024-10-31 | 19:01 ET | [10-Q](/filings/0001048477-24-000152.md) | Quarterly report, period 2024-09-30 | 0001048477-24-000152 |
| 2024-10-29 | 20:04 ET | [8-K](/filings/0001048477-24-000149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-24-000149 |
| 2024-09-24 | 12:31 ET | [8-K](/filings/0001193125-24-224139.md) | 7.01 Regulation FD disclosure | 0001193125-24-224139 |
| 2024-09-04 | 16:52 ET | [8-K](/filings/0001048477-24-000136.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001048477-24-000136 |
| 2024-08-28 | 21:02 ET | [8-K](/filings/0001048477-24-000132.md) | 2.05 Exit or disposal costs | 0001048477-24-000132 |
| 2024-08-22 | 21:00 ET | [8-K](/filings/0001193125-24-205405.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-205405 |
| 2024-08-05 | 20:35 ET | [10-Q](/filings/0001048477-24-000126.md) | Quarterly report, period 2024-06-30 | 0001048477-24-000126 |
| 2024-08-05 | 20:05 ET | [8-K](/filings/0001048477-24-000125.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-24-000125 |

Page 1 of 7. [Older](/companies/bmrn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.